PRCT
PROCEPT BioRobotics Corporation Common StockstockNASDAQ
Market OpenNov 19, 2026 3:38:06 PM EST
25.80USD+2.422%(+0.61)960,703
PRCT Financials
In Q3 FY 2026 (ended ), PROCEPT BioRobotics Corporation Common Stock (PRCT) reported revenue of $98.29M, net income of −$26.52M, operating cash flow of −$8.99M, and assets of $473.76M (filed ).
Loading financial statements…